U.S. stocks extended gains midway through trading, with the Dow Jones gaining around 250 points on Wednesday ahead of the release of minutes from the Fed's meeting.
Geron Corporation (NASDAQ:GERN) announced topline results from its IMerge Phase 3 trial of imetelstat, in lower-risk myelodysplastic syndromes (MDS) patients who…
Gainers
Elys Game Technology, Corp. (NASDAQ: ELYS) shares rose 63.2% to $0.4201 in pre-market trading after dropping 8% on Tuesday. Elys Game Technology and Cloakbook were recently granted a license to commence sportsbook operations in Washington, D.C.
Geron Corporation (NASDAQ:GERN) today announced that it will host a conference call to discuss top-line results from the IMerge Phase 3 clinical trial of imetelstat, the Company's first-in-class telomerase inhibitor,
Geron (NASDAQ:GERN) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Geron missed estimated earnings by 11.11%, reporting an EPS of $-0.1 versus an estimate of $-0.09.
Geron (NASDAQ:GERN) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that Geron will report an earnings per share (EPS) of $-0.09.
U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.